FDA Delays Approval for Migraine Drug Trexima
Trexima, a combination of sumatriptan (Imitrex) and naproxen sodium (found in Aleve and other NSAIDs), was expected to receive FDA approval last week. Requesting more safety data, the FDA has delayed approval of Trexima. The concern is about one of the four tests of genotoxicity,…